Marinol in Trichotillomania or Obsessive Compulsive Disorder
Status:
Completed
Trial end date:
2011-02-01
Target enrollment:
Participant gender:
Summary
The goal of the proposed study is to evaluate the efficacy and safety of dronabinol in
individuals with obsessive-compulsive disorder (OCD) or the obsessive-compulsive spectrum
disorders, trichotillomania (TTM) or pathological skin picking (PSP). Fifteen patients with
OCD, TTM, or PSP will receive 12 weeks of open-label treatment with dronabinol. The
hypothesis to be tested is that dronabinol will be effective and well tolerated in patients
with these disorders. The proposed study will provide needed data on the treatment of a
disabling disorder that currently lacks a clearly effective treatment.